SS Innovations International

SSII

Market cap $1.89B

Investing in emerging technologies is never for the faint of heart. These companies often trade more on potential than on current results, making them volatile and unpredictable.

Company successfully completed a human factors validation study at Johns Hopkins Hospital Anticipates submitting a 510(k) premarket notification to the FDA in the fourth quarter of 2025 Fort Lauderdale, FL, October 2, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.

Company successfully completed a human factors validation study at Johns Hopkins Hospital Anticipates submitting a 510(k) premarket notification to the FDA in the fourth quarter of 2025 FORT LAUDERDALE, Fla., Oct. 02, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company successfully completed a human factors validation study for its SSi Mantra surgical robotic system (the “SSi Mantra”) at Johns Hopkins Hospital in September 2025 and anticipates submitting a 510(k) premarket notification to the United States Food and Drug Administration (the “FDA”) for the SSi Mantra for multiple specialty indications in the fourth quarter of 2025.

Fort Lauderdale, FL – September 26, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.

FORT LAUDERDALE, Fla., Sept. 26, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Naveen Kumar Amar as the Company's Chief Financial Officer, effective September 24, 2025.

Showcases SSi Mantra's strengths in robotic telesurgery and opportunity in pediatrics Fort Lauderdale, FL – September 16, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.

SS Innovations Successful Completion of World's First Pediatric Pyeloplasty Telesurgery Utilizing the Company's SSi Mantra Surgical Robotic System

Marks another milestone in the Company's mission to bring advanced surgical robotic care to underserved patient populations Fort Lauderdale, FL, September 9, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – SS Innovations International, Inc.

FORT LAUDERDALE, Fla., Sept. 09, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the successful completion of the first robotic telesurgery performed from the Company's MantraM mobile robotic telesurgery unit (the “MantraM bus”).

Ss Innovations (SSII) Q2 Revenue Up 122%